FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
Infliximab (marketd as Remicade) Information
FDA has approved Remicade (infliximab) to treat children with Crohn’s disease who have moderately to severely active Crohn’s disease.
Back to Top Back to Drug Index
PDF requires the free Adobe Acrobat Reader
Date created: May 19, 2006
CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page
FDA/Center for Drug Evaluation and Research
(5/19/2006)
